Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorWonju Severance Christian Hospital
About this trial
By using genetic information we could predict the prevalence of mood disorder and response to treatment.
Eligibility criteria
Qualifiers
CKD patients aged 18 to 90 years
Disqualifiers
no CKD patients, aged below 18 or above 90 years
Trial design
Treatments tested in this trial
- Antidepressants
Treatment groups
300 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov